tetano
Editor, Senior Moderator
J Infect Dev Ctries. 2020 Mar 31;14(3):265-267. doi: 10.3855/jidc.12734.
As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation.
Rubino S[SUP]1[/SUP], Kelvin N[SUP]2[/SUP], Bermejo-Martin JF[SUP]3[/SUP], Kelvin D[SUP]4[/SUP].
Author information
Abstract
COVID-19 case fatalities surged during the month of March 2020 in Italy, reaching over 10,000 by 28 March 2020. This number exceeds the number of fatalities in China (3,301) recorded from January to March, even though the number of diagnosed cases was similar (85,000 Italy vs. 80,000 China). Case Fatality Rates (CFR) could be somewhat unreliable because the estimation of total case numbers is limited by several factors, including insufficient testing and limitations in test kits and materials, such as NP swabs and PPE for testers. Sero prevalence of SARS-CoV-2 antibodies may help in more accurate estimations of the total number of cases. Nevertheless, the disparity in the differences in the total number of fatalities between Italy and China suggests investigation into several factors, such as demographics, sociological interactions, availability of medical equipment (ICU beds and PPE), variants in immune proteins (e.g., HLA, IFNs), past immunity to related CoVs, and mutations in SARS-CoV-2, could impact survival of severe COVID-19 illness survival and the number of case fatalities.
Copyright (c) 2020 Salvatore Rubino, Nikki Kelvin, Jes?s F Bermejo-Martin, David Kelvin.
KEYWORDS:
COVID-19; Case Fatality Rates; Immunity; Italy; Novel coronavirus; SARS-CoV-19
PMID:32235086DOI:10.3855/jidc.12734
Free full text
As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation.
Rubino S[SUP]1[/SUP], Kelvin N[SUP]2[/SUP], Bermejo-Martin JF[SUP]3[/SUP], Kelvin D[SUP]4[/SUP].
Author information
Abstract
COVID-19 case fatalities surged during the month of March 2020 in Italy, reaching over 10,000 by 28 March 2020. This number exceeds the number of fatalities in China (3,301) recorded from January to March, even though the number of diagnosed cases was similar (85,000 Italy vs. 80,000 China). Case Fatality Rates (CFR) could be somewhat unreliable because the estimation of total case numbers is limited by several factors, including insufficient testing and limitations in test kits and materials, such as NP swabs and PPE for testers. Sero prevalence of SARS-CoV-2 antibodies may help in more accurate estimations of the total number of cases. Nevertheless, the disparity in the differences in the total number of fatalities between Italy and China suggests investigation into several factors, such as demographics, sociological interactions, availability of medical equipment (ICU beds and PPE), variants in immune proteins (e.g., HLA, IFNs), past immunity to related CoVs, and mutations in SARS-CoV-2, could impact survival of severe COVID-19 illness survival and the number of case fatalities.
Copyright (c) 2020 Salvatore Rubino, Nikki Kelvin, Jes?s F Bermejo-Martin, David Kelvin.
KEYWORDS:
COVID-19; Case Fatality Rates; Immunity; Italy; Novel coronavirus; SARS-CoV-19
PMID:32235086DOI:10.3855/jidc.12734
Free full text